Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
Patients after percutaneous coronary intervention (PCI) with stent implantation and functional hyporesponsiveness to P2Y12 inhibitors are at higher risk of ischaemic events, particularly stent thrombosis (ST). It is currently not routine practice to assess the functional response to these agents. Ho...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2016/2096181 |
id |
doaj-a9276fe141c241e69910a01415dbb608 |
---|---|
record_format |
Article |
spelling |
doaj-a9276fe141c241e69910a01415dbb6082020-11-24T23:49:12ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352016-01-01201610.1155/2016/20961812096181Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short ThromboelastographyBartosz Olechowski0Alexander Ashby1Nalyaka Sambu2Michael Mahmoudi3Nick Curzen4Wessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UKWessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UKWessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UKWessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UKWessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UKPatients after percutaneous coronary intervention (PCI) with stent implantation and functional hyporesponsiveness to P2Y12 inhibitors are at higher risk of ischaemic events, particularly stent thrombosis (ST). It is currently not routine practice to assess the functional response to these agents. However, concern over functional hyporesponsiveness to clopidogrel has led to widespread uptake of prasugrel and ticagrelor as the default P2Y12 inhibitor after stent implantation in patients with acute coronary syndrome. Here we report, for the first time, 3 cases in which patients who have had ST exhibit hyporesponsiveness to clopidogrel, prasugrel, and ticagrelor.http://dx.doi.org/10.1155/2016/2096181 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bartosz Olechowski Alexander Ashby Nalyaka Sambu Michael Mahmoudi Nick Curzen |
spellingShingle |
Bartosz Olechowski Alexander Ashby Nalyaka Sambu Michael Mahmoudi Nick Curzen Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography Case Reports in Medicine |
author_facet |
Bartosz Olechowski Alexander Ashby Nalyaka Sambu Michael Mahmoudi Nick Curzen |
author_sort |
Bartosz Olechowski |
title |
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography |
title_short |
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography |
title_full |
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography |
title_fullStr |
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography |
title_full_unstemmed |
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography |
title_sort |
stent thrombosis patients with hyporesponsiveness to clopidogrel, prasugrel, and ticagrelor: a case series using short thromboelastography |
publisher |
Hindawi Limited |
series |
Case Reports in Medicine |
issn |
1687-9627 1687-9635 |
publishDate |
2016-01-01 |
description |
Patients after percutaneous coronary intervention (PCI) with stent implantation and functional hyporesponsiveness to P2Y12 inhibitors are at higher risk of ischaemic events, particularly stent thrombosis (ST). It is currently not routine practice to assess the functional response to these agents. However, concern over functional hyporesponsiveness to clopidogrel has led to widespread uptake of prasugrel and ticagrelor as the default P2Y12 inhibitor after stent implantation in patients with acute coronary syndrome. Here we report, for the first time, 3 cases in which patients who have had ST exhibit hyporesponsiveness to clopidogrel, prasugrel, and ticagrelor. |
url |
http://dx.doi.org/10.1155/2016/2096181 |
work_keys_str_mv |
AT bartoszolechowski stentthrombosispatientswithhyporesponsivenesstoclopidogrelprasugrelandticagreloracaseseriesusingshortthromboelastography AT alexanderashby stentthrombosispatientswithhyporesponsivenesstoclopidogrelprasugrelandticagreloracaseseriesusingshortthromboelastography AT nalyakasambu stentthrombosispatientswithhyporesponsivenesstoclopidogrelprasugrelandticagreloracaseseriesusingshortthromboelastography AT michaelmahmoudi stentthrombosispatientswithhyporesponsivenesstoclopidogrelprasugrelandticagreloracaseseriesusingshortthromboelastography AT nickcurzen stentthrombosispatientswithhyporesponsivenesstoclopidogrelprasugrelandticagreloracaseseriesusingshortthromboelastography |
_version_ |
1725483407649013760 |